Evidence map›Paper›PMID 23730214›Full record

ArticleNeoplasia (New York, N.Y.)2013

CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast cancer cells.

Gergana Metodieva, Naiara Correa Nogueira-de-Souza, Christina Greenwood, Khalid Al-Janabi, Lin Leng, Richard Bucala, Metodi V Metodiev

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Mapping malignant T-cell states and immune circuits in Sézary syndrome by single-cell analysis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Gergana MetodievaProteomics Unit, Department of Biological Sciences, University of Essex, Colchester, Essex, United Kingdom.
Naiara Correa Nogueira-de-Souza
Christina Greenwood
Khalid Al-Janabi
Lin Leng
Richard Bucala
Metodi V Metodiev
University of Essex · GBYale University · USAnglia Ruskin University · GBBroomfield Hospital · GB

Funding

Identification of new markers and drug target candidates for triple negative breaR03CA150131 · NCI · UNIVERSITY OF ESSEX · PI METODIEV, METODI V · 2011 to 2012
$99k
NCI NIH HHS 1R03CA150131NCI NIH HHS R03 CA150131
6 · The paper itself

Abstract

The γ subunit of the major histocompatibility complex (MHC) class II complex, CD74, is overexpressed in a significant proportion of metastatic breast tumors, but the mechanistic foundation and biologic significance of this phenomenon are not fully understood. Here, we show that when CD74 is overexpressed in human cancer and noncancerous epithelial cells, it interacts and interferes with the function of Scribble, a product of a well-known tumor suppressor gene. Furthermore, using epithelial cell lines expressing CD74 under the control of tetracycline-inducible promoter and quantitative high-resolution mass spectrometry, we demonstrate that, as a result of CD74 overexpression, the phosphorylation pattern of the C-terminal part of Scribble undergoes specific changes. This is accompanied with a translocation of the protein from the sites of cell-to-cell contacts at the plasma membrane to the cytoplasm, which is likely to effectively enhance the motility and invasiveness of the cancer cells.

Indexed as

Amino Acid SequenceAntigens, Differentiation, B-LymphocyteBreast NeoplasmsCell LineCell Line, TumorCell MembraneCytoplasmEpithelial CellsFemaleGene Expression RegulationGene Knockdown TechniquesHistocompatibility Antigens Class IIHumansMembrane ProteinsMolecular Sequence DataPhosphorylationAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIinvariant chainMembrane ProteinsSCRIB protein, humanTumor Suppressor Proteins

Identifiers

PMID23730214
PMCPMC3664998
OpenAlexW1239260777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.